Studien

Die Klinik beteiligt sich aktuell an folgenden medizinisch-wissenschaftlichen Studien:

• Prevention of cerebrovascular and cardiovascular events of ischaemic origin with terutroban in patients with a history of ischaemic stroke or transient ischaemic attack (PERFORM)  - aktuelle Studie

• Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-3) - aktuelle Studie

• Stent Protected Angioplasty versus Carotid Endarterectomy (SPACE 2) – aktuelle Studie

• EXCITIG – aktuelle Studie
  A 16-week, multicenter, double-blind, randomized, placebo-controlled, parallel group study to evaluate the efficacy of rivastigmine (Exelon® patch 10 cm2) on cognitive deficits in patients with multiple sclerosis, followed by a 1-year open-label treatment phase